Skin patch to help those with dementia, approved
Hopefully, this is good news and there won't be some recall a year from now that has found some horrid side effect, but the FDA has approved a new skin patch to treat dementia associated with Alzheimer's patients.
The patch is called Exelon. There is a capsule form of the drug, but the patch will provide a continuous dose throughout the day, according to drug makers Novartis Pharmaceuticals Corp. The patch will help those with mild to moderate symptoms.
From the Associated Press story:
Rivastigmine isn't a cure. It inhibits the breakdown of a chemical in the brain called acetylcholine, thought important for both learning and memory.Novartis said the prescription patch would be available soon.